Form 4 for KURA Kura Oncology, Inc.
Accepted 2022-01-28 00:00:00 ET · period of report 2022-01-26 · accession 0001209191-22-005391 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-28 | 2022-01-26 | KURA | GRASSO MARC | CFO, CBO | A - Grant | $0.00 | +21.9K | 21.9K | New | $0 |
| D | 2022-01-28 | 2022-01-26 | KURA | GRASSO MARC | CFO, CBO | A - Grant | $0.00 | +131.0K | 131.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-26 | A | A | 21,900 | $0.00 | 21,900 | D | — | — | (F1) Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/23, 1/26/24, 1/26/25 and 1/26/26. |
| 2 | Derivative | Option to purchase common stock | 2022-01-26 | A | A | 131,000 | $0.00 | 131,000 | D | $14.15 · — to 2032-01-25 | 131,000 Common Stock | (F2) This option vests in 48 equal monthly installments commencing on the grant date. |